Gold smuggling: Involvement of Customs staffers at Mangaluru Airport raises eyebrows

Mangaluru, July 15: Moulana Iqbal Mulla Nadvi, an acclaimed Islamic scholar and Qadhi (Khazi) of Bhatkal, passed away at a private hospital in Mangaluru. 

The elderly scholar was critically for past few weeks. 

He had served as the president of Jamia Islamia Bhatkal for several years.

He was known among Islamic scholars of Karnataka for his boldness, sincerity and wisdom.

Last rites are expected to be held in Bhatkal.

More details are awatied. 

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Udupi, Jun 28: The Padubidri police have booked cases against two patients of Novel Coronavirus for not revealing their primary contacts and hiding their travel history.

According to DHO Sudhirchandra Sooda, two siblings from Hejamadi in Padubidri had tested positive for COVID-19 recently. After shifting to the hospital, when the officials asked them about their primary contacts and travel history, the patients furnished false information.

When the officials collected information from various sources, they realised that the duo had travelled to Bantwal, Kasargod, Ullal and other places in Dakshina Kannada, said Dr Sooda. Hence, the district administration decided to file cases against them, he added.